Anticardiolipin antibodies in chronic hepatitis B and chronic hepatitis D infection, and hepatitis B-related hepatocellular carcinoma. Relationship with portal vein thrombosis

European Journal of Gastroenterology and Hepatology

Volumn 15, Issue 7, 2003, Pages 721-726

  Elefsiniotis, Ioannis S ^a,b   Diamantis, Ioannis D ^c   Dourakis, Spyros P ^a   Kafiri, Georgia ^a   Pantazis, Konstantinos ^a   Mavrogiannis, Christos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b 'Hippokration' Hospital ^*  (Greece)

^c NONE

Author keywords

Anticardiolipin antibodies; HBV; HDV; Hepatocellular carcinoma; Portal vein thrombosis

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CHRONIC HEPATITIS; CLINICAL FEATURE; CONTROLLED STUDY; DELTA AGENT HEPATITIS; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; SEROLOGY;

EID: 0038163754     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000059140.68845.74     Document Type: Article

References (32)

1. Okuda K, Ohnishi K, Kimura K, Matsutani S, Goto N, Musha H, et al. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology 1985; 89:279-288.
2. Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 2000; 32:865-871.
3. Starlz TE, Demetris AJ, Van Thiel D. Liver transplantation. N Engl J Med 1989; 321:1014-1022.
4. Nonami T, Yokoyama I, Iwatsuki S, Starzl TE. The incidence of portal vein thrombosis at liver transplantation. Hepatology 1992; 16:1195-1198.
5. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353:1167-1173.
6. Denninger MH, Chait Y, Casaderall N, Hillaire S, Guillin MC, Bezeaud A, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000; 31:587-591.
7. Bick RL. Antiphospholipid thrombosis syndromes: etiology, pathophysiology, diagnosis and management. Int J Hematol 1997; 65:193.
8. Bick RL. The antiphospholipid thrombosis syndromes: fact, fiction, confusion and controversy. Am J Clin Pathol 1993; 100:477.
9. Bick RL. The antiphospholipid thrombosis syndromes: lupus anticoagulants and anticardiolipin antibodies. Adv Pathol Lab Med 1995; 8:391.
10. Bick RL, Baker WF. Anticardiolipin antibodies and thrombosis. Hematol Oncol Clin North Am 1992; 6:1287.
11. Mangia A, Margaglione M, Cascavilla I, Gentile R, Cappucci G, Facciorusso D, et al. Anticardiolipin antibodies in patients with liver disease. Am J Gastroenterol 1999; 94:2983-2987.
12. Prieto J, Yuste JR, Beloqui O, Civeira M, Riezu JI, Aguirre B, Sangro P. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 1996; 23:199-204.
13. Harada M, Fujisawa Y, Sakisaka S, Kawaguchi T, Taniguchi E, Sakamoto M, et al. High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications. J Gastroenterol 2000; 35:272-277.
14. Dalekos GN, Kistis KG, Boumba DS, Voulgari P, Zervou EK, Drosos AA, Tsianos EV. Increased incidence of anticardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to antiphospholipid syndrome. Eur J Gastroenterol Hepatol 2000; 12:67-74.
15. Munoz-Rodriguez FJ, Tassies D, Font J, Reverter JC, Cervera R, Sanchez-Tapias JM, et al. Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome. J Hepatol 1999; 30:770-773.
16. 2-glycoprotein-I. Proc Natl Acad Sci USA 1990; 87:4120-4124.
17. McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991; 29:193-280.
18. Dourakis SP, Michael AE, Papanikolaou IS, Nomikou E, Thalassinou P, Hadziyannis S. Autoimmune hepatitis associated with the antiphospholipid syndrome. Eur J Gastroenterol Hepatol 2001; 13:591-593.
19. Pathmakanthan S, Kay EW, Murray FE. Autoimmune chronic active hepatitis associated with the presence of antiphospholipid antibodies. Eur J Gastroenterol Hepatol 1998; 10:155-157.
20. 2-glycoprotein-I and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. J Rheumatol 1997; 24:2139-2144.
21. Stoeger ZM, Fogel M, Smirov A, Ergas D, Lurie Y, Bass DD, et al. Anticardiolipin autoantibodies in serum samples and cryoglobulins of patients with chronic hepatitis C infection. Ann Rheum Dis 2000; 59:483-486.
22. Gregorio GV, Jones H, Choudhuri K, Vegnente A, Bortolotti F, Mieli-Vergani G, Vergani D. Autoantibody prevalence in chronic hepatitis B virus infection: effect of interferon alfa. Hepatology 1996; 24:520-523.
23. Weber P, Wiedmann KH, Klein R, Blum HE, Berg PA. Induction of autoimmune phenomenon in patients with chronic hepatitis B treated with gamma-interferon. J Hepatol 1994; 20:321-328.
24. Guglielmone H, Vitozzi S, Elbarcha O, Fernandez E. Cofactor dependence and isotype distribution of anticardiolipin antibodies in viral infections. Ann Rheum Dis 2001; 60:500-504.
25. Biron C, Andreani H, Blanc P, Ramps J, Guigue N, Larrey D. Prevalence of antiphospholipid antibodies in patients with chronic liver disease related to alcohol or hepatitis C virus: correlation with liver injury. J Lab Clin Med 1998; 131:243-250.
26. Neurath AR, Strick N. The putative cell receptors for hepatitis B virus, annexin-V and apolipoprotein-H bind to lipid components of HBV. Virology 1994; 204:475-477.
27. Gotoh M, Matsuda J. Human immunodeficiency virus rather than hepatitis C virus infection is relevant to the development of an anticardiolipid antibody. Am J Hematol 1997; 50:220-222.
28. 2-glycoprotein-I antibodies, in HIV infection. Clin Immunol Immunopathol 1995; 77:69-74.
29. Bick RL. Coagulation abnormalities in malignancy. Semin Thromb Hemost 1992; 18:353-372.
30. Aggarwal R, Ravishankar B, Misra R, Aggarwal A, Dwivedi S, Naik SR. Significance of elevated IgG anticardiolipin antibody levels in patients with Budd-Chiari syndrome. Am J Gastroenterol 1998; 93:954-957.
31. Asherson RA, Khamasta MA, Huges GRV. Hepatic complications of the antiphospholipid syndrome. Clin Exptal Rheumatol 1991; 9:341-344.
32. Mor F, Beigel Y, Inbal A, Goren M, Wysenbeek AJ. Hepatic infarction in a patient with the lupus anticoagulant. Arthritis Rheum 1989; 32:491-495.